Atlas Trials

Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

Clinical trial NCT05453916 · WITHDRAWN

Trial details

NCT number
NCT05453916
Sponsor
Sadat City University
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Irritable Bowel Syndrome With Diarrhea
Start date
2022-07-01
Primary completion
2024-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.